The Role of SGLT2 Inhibitor Ipragliflozin on Cardiac Hypertrophy and microRNA Expression Profiles in a Non-diabetic Rat Model of Cardiomyopathy
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details